{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030025_S017","text":"Approval to change the in-process coating weight acceptance criteria.  The device, as modified, will be marketed under the trade name taxus express2 paclitaxel-eluting coronary stent system and is indicated for improving luminal diameter for the treatment of de novo lesions \u003C28 mm in length in native coronary arteries \u003E=2.5 to \u003C=3.75 mm in diameter.","project":"consensus_PMA_Age_Indications"}